The effects of HMG-CoA reductase inhibitors on disease activity in multiple sclerosis: A systematic review and meta-analysis
Maria‐Ioanna Stefanou, Lina Palaiodimou, Aristeidis H. Katsanos, Haralampos Milionis, Maria Kosmidou, Vaia Lambadiari, Panagiotis Halvatsiotis, Panagiotis Ferentinos, Elizabeth Andreadou, Γεώργιος Μαρίνος, Aikaterini Theodorou, John S. Tzartos, Konstantinos Voumvourakis, Georgios Tsivgoulis, Sotirios Giannopoulos
Topics & Concepts
MedicineMultiple sclerosisSimvastatinInternal medicineStatinMeta-analysisRandomized controlled trialOdds ratioConfidence intervalClinically isolated syndromeHMG-CoA reductaseClinical trialOncologyReductaseImmunologyEnzymeBiochemistryChemistryMultiple Sclerosis Research StudiesOcular Diseases and Behçet’s SyndromeSystemic Lupus Erythematosus Research